logo

Edgewise Therapeutics Stock Shoots Higher On Promising Early Results For Thickened Heart Treatment - Edgewise Therapeutics ( NASDAQ:EWTX )

  13 hours ago   
post image
On Thursday, Edgewise Therapeutics Inc. EWTX released announced topline data of EDG-7500 from the Phase 1 trial in healthy subjects and the single-dose arm of the Phase 2 CIRRUS-HCM trial for obstructive hypertrophic cardiomyopathy.
Ticker Sentiment Impact
EWTX
Neutral
28 %